Medical devices

Insights on the Neurostimulation Devices Global Market to 2026 - Rise in Number of People Suffering from Hearing Loss is Driving Growth - ResearchAndMarkets.com

Retrieved on: 
Monday, September 6, 2021

Neurostimulation is used as a key element in neural prosthetics for hearing aids, artificial vision, artificial limbs, brain-machine interfaces, etc.

Key Points: 
  • Neurostimulation is used as a key element in neural prosthetics for hearing aids, artificial vision, artificial limbs, brain-machine interfaces, etc.
  • the growth in the neurostimulation devices market may be attributed to the increasing prevalence of chronic neuromuscular disorder and the rising adoption of these devices by the physicians.
  • However, stringent regulations of the neurostimulation devices and lack of skilled professionals for performing the surgeries might restrain the market growth during the given time frame.
  • The market is expected to surge in the coming years, due to the rise in the number of people, suffering from hearing loss and other related concerns.

Eurofins Strengthens Its Global Leadership Position in Cosmetics and Personal Care Products Testing and Clinical Services and Grows Its Position in Dermatology Drug Testing

Retrieved on: 
Wednesday, August 4, 2021

Eurofins (Paris:ERF) Cosmetics & Personal Care Testing Business line is the leading provider in cosmetics suncare and personal care testing worldwide, offering the most comprehensive range of testing and clinical services from 26 state-of-the-art laboratories in Europe, North America, Asia-Pacific and Africa and unrivalled customer service.

Key Points: 
  • Eurofins (Paris:ERF) Cosmetics & Personal Care Testing Business line is the leading provider in cosmetics suncare and personal care testing worldwide, offering the most comprehensive range of testing and clinical services from 26 state-of-the-art laboratories in Europe, North America, Asia-Pacific and Africa and unrivalled customer service.
  • Supported by 16 clinical laboratories, Eurofins Cosmetics & Personal Care testing offers unmatched clinical capabilities and innovation worldwide.
  • Over the last 30 years bioskin has built a reputation for excellence in providing clinical trials in dermatology for medicinal products and for medical devices.
  • Eurofins CEO, Gilles Martin commented: "Cosmetics suncare and personal care Products have an impact on our health and well-being.

LivaNova Prices Offering of Ordinary Shares

Retrieved on: 
Wednesday, August 4, 2021

LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced that it has priced an underwritten offering of 3,636,364 ordinary shares at a price to the public of $82.50 per share.

Key Points: 
  • LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced that it has priced an underwritten offering of 3,636,364 ordinary shares at a price to the public of $82.50 per share.
  • The Company also granted the underwriters a 30-day option to acquire up to 545,454 additional ordinary shares offered on the same terms as the initial shares.
  • The net proceeds of the offering are expected to be approximately $280.1 million (or approximately $322.4 million if the underwriters exercise in full the option to acquire additional ordinary shares), after deducting underwriting discounts and commissions and estimated offering expenses payable by LivaNova.
  • The ordinary shares are only available to, and any invitation, offer or agreement to subscribe, purchase or otherwise acquire such ordinary shares will be engaged in only with, Relevant Persons.

MDIC Adds New Board Chair and New Board Members

Retrieved on: 
Tuesday, August 3, 2021

The Medical Device Innovation Consortium (MDIC) today announced that Dr. Jijo James, Chief Medical Officer, Medical Devices and Global External Innovation at Johnson & Johnson, has begun his role as chair of the MDIC Board of Directors.

Key Points: 
  • The Medical Device Innovation Consortium (MDIC) today announced that Dr. Jijo James, Chief Medical Officer, Medical Devices and Global External Innovation at Johnson & Johnson, has begun his role as chair of the MDIC Board of Directors.
  • MDIC President and CEO, Pamela Goldberg is, Excited to add their incredible expertise to our already impressive board to help in guiding our future.
  • Dr. Jijo James has served on the MDIC Board of Directors since 2017 and has been a member of the MDIC Executive Committee since 2018.
  • Im honored to help lead MDIC and learn from its members as the organization continues to leverage its unique position to transform health care into people- and patient-focused care.

Camber Spine Receives FDA Clearance for SPIRA-P and SPIRA-T Technologies

Retrieved on: 
Tuesday, August 3, 2021

Camber Spine , a leading innovator in spine and medical technologies, announced today that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for both its SPIRA-P Posterior Lumbar Spacer technology and SPIRA-T Oblique Posterior Lumbar Spacer technologies.

Key Points: 
  • Camber Spine , a leading innovator in spine and medical technologies, announced today that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for both its SPIRA-P Posterior Lumbar Spacer technology and SPIRA-T Oblique Posterior Lumbar Spacer technologies.
  • The SPIRA-T Oblique Posterior Lumbar Spacer features the same qualities, but is designed specifically to accommodate traditional or insert and rotate TLIF procedures.
  • Innovative spine and medical technology company Camber Spine Technologies is dedicated to creating surgeon-designed solutions in MIS and minimally disruptive access for the treatment of complex spinal pathology.
  • Incorporating state-of-the-art manufacturing, 3-D printing, and an acute sensitivity to patient anatomy, Camber Spine is making quantum leaps in the spinal fusion market.

Topcon Healthcare to Partner with RetInSight

Retrieved on: 
Tuesday, August 3, 2021

Topcon Healthcare of Oakland, NJ, a leading provider of medical devices and software solutions for the global eye care community, announced today that it will partner with RetInSight GmbH, a developer of retina AI solutions based in Vienna, Austria.

Key Points: 
  • Topcon Healthcare of Oakland, NJ, a leading provider of medical devices and software solutions for the global eye care community, announced today that it will partner with RetInSight GmbH, a developer of retina AI solutions based in Vienna, Austria.
  • RetInSights novel, proprietary algorithms aim to support clinicians in the detection, quantification, and monitoring of key retinal biomarkers including retinal fluid and geographic atrophy lesions.
  • With this collaboration, Topcon and RetInSight hope to extend retinal fluid detection and monitoring to primary eye care providers, facilitating co-management of patients.
  • We are very pleased to add this powerful module to our already robust Harmony clinical data management solution and to our world-leading OCTs, said Tobias Kurzke, Director of Product Management for Topcon Healthcare.

Live Cell Imaging Global Market Report 2021: COVID-19 Growth and Change to 2030 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, August 3, 2021

The "Live Cell Imaging Global Market Report 2021: COVID-19 Growth and Change" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Live Cell Imaging Global Market Report 2021: COVID-19 Growth and Change" report has been added to ResearchAndMarkets.com's offering.
  • Live Cell Imaging Global Market Report 2021: COVID-19 Growth and Change provides the strategists, marketers and senior management with the critical information they need to assess the global live cell imaging market.
  • The global live cell imaging market is expected to grow from $3.61 billion in 2020 to $3.98 billion in 2021 at a compound annual growth rate (CAGR) of 10.3%.
  • The live cell imaging market consists of sales of live cell imaging by entities (organizations, sole traders, and partnerships) that are engaged in manufacturing and selling live cell imaging equipment and consumables.

Global Endodontics Devices Market (2021 to 2025) - Featuring Aseptico, Brasseler and Kerr Among Others - ResearchAndMarkets.com

Retrieved on: 
Tuesday, August 3, 2021

The "Global Endodontics Devices Market 2021-2025" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Endodontics Devices Market 2021-2025" report has been added to ResearchAndMarkets.com's offering.
  • The publisher has been monitoring the endodontics devices market and it is poised to grow by $370.83 million during 2021-2025, progressing at a CAGR of over 5% during the forecast period.
  • The report on the endodontics devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
  • The endodontics devices market analysis includes the product segment and geographic landscape.